Hologic, Inc.

Hologic, Inc. is a leading global medical technology company specializing in diagnostic solutions, women’s health, molecular diagnostics, breast imaging, cytology, and surgical products. Founded in 1985 and headquartered in Marlborough, Massachusetts, United States, the company develops innovative technologies that enable early disease detection, accurate diagnosis, and minimally invasive treatment.

Hologic is internationally recognized for its leadership in women’s health diagnostics, particularly in breast cancer screening, cervical cancer detection, sexually transmitted infection (STI) testing, prenatal screening, and molecular diagnostic assays. Its product portfolio includes 3D mammography systems, molecular diagnostic platforms, cytology systems, pathology solutions, biopsy devices, and gynecologic surgical technologies. The company also offers laboratory automation and digital healthcare solutions that improve workflow efficiency in hospitals and clinical laboratories.

The company invests heavily in artificial intelligence, molecular biology, automation, and advanced imaging technologies to support precision diagnostics and improve patient outcomes. Hologic’s research centers and manufacturing facilities comply with international regulatory standards established by the US FDA, European IVDR, ISO 13485, and other major healthcare authorities.

With decades of innovation and a strong commitment to women’s health, Hologic has become one of the world’s most trusted diagnostic companies, helping healthcare professionals detect diseases earlier and deliver more effective patient care.